The impact of growth conditions on biofilm formation and the cell surface hydrophobicity in fluconazole susceptible and tolerant Candida albicans. 2015

Anna Kolecka, and Dušan Chorvát, and Helena Bujdáková
Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Mlynska dolina B-2, 842 15, Bratislava, Slovakia.

The influence of acidic (5.6) and neutral (7.0) pH and glucose concentrations (0.9 and 2 %) was determined in in vitro biofilm formation and the cell surface hydrophobicity (CSH) in fluconazole (FLC) susceptible and tolerant yeasts of Candida albicans. The determination of biofilm viability using tetrazolium salt XTT showed that both FLC-tolerant C. albicans 1173 and FLC-sensitive C. albicans SC 5314 formed more robust biofilm in the YNB medium at pH 7.0 in the absence of FLC than that at acidic pH. Tested glucose concentrations did not show any direct effect on formation of biofilm under all conditions. However, determination of biofilm dry mass that contains also extracellular matrix suggested some effect of 2 % D-glucose. An increase in CSH (for about 10 %) was estimated in C. albicans SC 5314 in the presence of FLC, while the FLC-tolerant isolate proved a weak increase of CSH only in the YNB media containing 2 % D-glucose. Additionally, strain C. albicans SC 5314 strongly flocculated at neutral pH in the absence of FLC, but this phenomenon was not observed in the presence of FLC. Subinhibitory concentration of FLC influenced biofilm cells and CSH, but FLC susceptibility versus tolerance of C. albicans tested strains did not directly affect biofilm formation and/or CSH.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013499 Surface Properties Characteristics or attributes of the outer boundaries of objects, including molecules. Properties, Surface,Property, Surface,Surface Property
D015725 Fluconazole Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS. Apo-Fluconazole,Béagyne,Diflucan,Fluc Hexal,FlucoLich,Flucobeta,Fluconazol AL,Fluconazol AbZ,Fluconazol Stada,Fluconazol von ct,Fluconazol-Isis,Fluconazol-ratiopharm,Flunazul,Fungata,Lavisa,Loitin,Neofomiral,Oxifungol,Solacap,Triflucan,UK-49858,Zonal,Apo Fluconazole,Fluconazol Isis,Fluconazol ratiopharm,UK 49858,UK49858
D057927 Hydrophobic and Hydrophilic Interactions The thermodynamic interaction between a substance and WATER. Hydrophilic Interactions,Hydrophilic and Hydrophobic Interactions,Hydrophilicity,Hydrophobic Interactions,Hydrophobicity,Hydrophilic Interaction,Hydrophilicities,Hydrophobic Interaction,Hydrophobicities,Interaction, Hydrophilic,Interaction, Hydrophobic,Interactions, Hydrophilic,Interactions, Hydrophobic
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm

Related Publications

Anna Kolecka, and Dušan Chorvát, and Helena Bujdáková
October 1986, Infection and immunity,
Anna Kolecka, and Dušan Chorvát, and Helena Bujdáková
January 2018, PloS one,
Anna Kolecka, and Dušan Chorvát, and Helena Bujdáková
February 2000, FEMS microbiology letters,
Anna Kolecka, and Dušan Chorvát, and Helena Bujdáková
September 2008, Canadian journal of microbiology,
Anna Kolecka, and Dušan Chorvát, and Helena Bujdáková
April 1988, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology,
Anna Kolecka, and Dušan Chorvát, and Helena Bujdáková
January 2009, Medycyna doswiadczalna i mikrobiologia,
Anna Kolecka, and Dušan Chorvát, and Helena Bujdáková
March 2007, The Journal of antimicrobial chemotherapy,
Anna Kolecka, and Dušan Chorvát, and Helena Bujdáková
January 2020, Yeast (Chichester, England),
Anna Kolecka, and Dušan Chorvát, and Helena Bujdáková
August 2017, Journal of prosthodontics : official journal of the American College of Prosthodontists,
Copied contents to your clipboard!